Intervening on Reproductive Health in Young Breast Cancer Survivors
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- University of California, San Diego
- Enrollment
- 38
- Locations
- 2
- Primary Endpoint
- Hot Flash Frequency
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Most young breast cancer patients undergo chemotherapy and/or endocrine therapy, treatments that impair ovarian function and result in significant reproductive health late effects. These late effects include symptoms of estrogen deprivation (e.g., hot flashes and vaginal dryness), which are distressing in young breast cancer survivors (YBCS). The goal of this pilot study is to test the feasibility of a 4-week text message based intervention on hot flashes and vaginal dryness in YBCS. YBCS will be randomized in a 1:1 ratio to the intervention (text messages on hot flash and vaginal dryness management) and control arms. All participants will be prompted to provide daily hot flash frequency and severity via text messaging. The primary hypothesis is YBCS will have high rates of daily hot flash reporting via text messaging. Secondarily, we will compare changes in hot flash frequency, hot flash severity and vagina dryness between the intervention and control arms.
Investigators
Hui-Chun Irene Su
Assistant Professor of Reproductive Medicine
University of California, San Diego
Eligibility Criteria
Inclusion Criteria
- •Breast cancer
- •Completed primary breast cancer treatment
- •Age \<=45
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Hot Flash Frequency
Time Frame: 1 week
Median number of daily hot flashes over 4th week of study